Sylogist Ltd.
SYZLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -27.2% | -4% | 6.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 44% | 57.7% | 59.1% | 58.9% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 17.7% | 9% | 14.8% | 16.6% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -5.6% | -12.3% | -5.7% | 4.8% |
| EPS Diluted | -0.027 | -0.082 | -0.04 | 0.03 |
| % Growth | 66.8% | -105% | -233.8% | – |
| Operating Cash Flow | $0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | $0 | $0 |